The US geriatric medicine market is projected to witness a growth of 4.6% during the forecast period. The major factors contributing to the growth of the market include the increasing geriatric population and rising prevalence of cardiovascular diseases (CVDs). The country has the presence of some of the leading market players, such as Abbott Laboratories, Johnson & Johnson Services Inc., and Eli Lilly and Co. contributes to the significant growth in the demand for geriatric medicine in the US. 

Moreover, the country has the presence of research institutes that mainly focusses on geriatric health. American Geriatrics Society and The Gerontological Society of America are among the most renowned research centers governed by the Government of the US, focusing on the scientific study of aging and development of effective medical, biological, psychological, and social solutions for the geriatric population.  

The geriatric medicine market is classified on the basis of therapeutics and conditions. Based on therapeutics, the market is segmented into analgesic, anticoagulant, antihypertensive, antidiabetic, and others. Based on the condition, the market is segregated into CVDs, diabetes, neurological, cancer, respiratory, and others. Among these conditions, the CVDs segment contributes significantly to the market. The dominance of the segment is backed by the significant patient pool of CVDs across the globe. With the rise in age, the development of CVDs increases subsequently. Therefore, a huge market is covered by CVDs medicines in the geriatric medicine market. 

The US geriatric medicine market is influenced by product development and advancements conducted by the market players. The key players of the geriatric medicine market include Pfizer Inc., Bristol-Myers Squibb Co., Abbott Laboratories Inc., Johnson & Johnson Services Inc., Eli Lilly and Co., Merck & Co. Inc., and Boehringer Ingelheim GmbH. These players are playing a significant role in the growth of the geriatric medicine market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the US geriatric medicine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report is intended for drug manufacturers, pharmaceutical & biopharmaceutical companies, research institutes, academic institutes, industry associates & experts, government organizations, regulatory bodies, and other market participants for overall market analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. US Geriatric Medicine Market Research and Analysis by Therapeutics
2. US Geriatric Medicine Market Research and Analysis by Condition

The Report covers:

• Comprehensive research methodology of the US geriatric medicine market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US geriatric medicine market.
• Insights about market determinants which are stimulating the US market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.